학술논문
Trastuzumab deruxtecan in previously treated patients with HER2-positive metastatic breast cancer: updated survival results from a phase II trial (DESTINY-Breast01)
Document Type
Article
Author
Source
In Annals of Oncology March 2024 35(3):302-307
Subject
Language
ISSN
0923-7534